Literature DB >> 16153418

Pancreatic epithelial cells can be converted into insulin-producing cells by GLP-1 in conjunction with virus-mediated gene transfer of pdx-1.

Masayuki Koizumi1, Ryuichiro Doi, Koji Fujimoto, Daisuke Ito, Eiji Toyoda, Tomohiko Mori, Kazuhiro Kami, Yoshiya Kawaguchi, George K Gittes, Masayuki Imamura.   

Abstract

BACKGROUND: Glucagonlike peptide-1 (GLP-1) stimulates insulin secretion and proliferation by islet cells in vitro and in vivo, associated with an activation of pancreatic duodenal homeobox gene-1 (pdx-1) function. The effect of GLP-1 on the conditionally immortalized pancreatic epithelial cells (IMPE cells) is not clear when they are treated in conjunction with the adenovirus-mediated gene transfer of pdx-1.
METHODS: IMPE cells were established from the pancreas of H-2K(b)-tsA58 transgenic mice. IMPE cells were maintained at 33 degrees C with 10 U/mL interferon (IFN)-gamma and the experiments were performed at 39 degrees C without IFN-gamma. IMPE cells were infected with 20 multiplicities of Ad-pdx-1 or control Ad-lacZ at 39 degrees C without IFN-gamma and were incubated with various concentrations of GLP-1. After 48 hours, immunofluorescence and reverse transcriptase-polymerase chain reaction for insulin and pdx-1 expression were examined. Immunoreactive insulin in the cell lysate and supernatant was also analyzed. The glucose concentration in the culture medium was changed to test the insulin secretory responsiveness of the IMPE cells.
RESULTS: The treatment with GLP-1 in conjunction with Ad-pdx-1 induced insulin production by IMPE cells, but the treatment with either GLP-1 or Ad-pdx-1 alone failed to induce insulin production. Insulin production and secretion were increased by GLP-1 and by glucose in a dose-dependent manner. In addition, the insulin-producing IMPE cells acquired a rapid insulin secretory responsiveness to the changes of extracellular glucose concentration.
CONCLUSIONS: GLP-1 and pdx-1 work together to induce insulin-producing cells from IMPE cells, which bear unique characteristics of pancreatic ductal cells. The results suggest that GLP-1 may be another important determiner of pancreatic endocrine differentiation as is pdx-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153418     DOI: 10.1016/j.surg.2005.06.008

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats.

Authors:  Zhen Li; Hong-Ya Zhang; Lu-Xian Lv; Dong-Fei Li; Jing-Xing Dai; Ou Sha; Wen-Qiang Li; Yu Bai; Lin Yuan
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Secretion of insulinotropic proteins by commensal bacteria: rewiring the gut to treat diabetes.

Authors:  Faping Duan; Katherine L Curtis; John C March
Journal:  Appl Environ Microbiol       Date:  2008-10-03       Impact factor: 4.792

Review 3.  Mechanisms of action of glucagon-like peptide 1 in the pancreas.

Authors:  Máire E Doyle; Josephine M Egan
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

Review 4.  Establishment of conditionally immortalized epithelial cell lines from the intestinal tissue of adult normal and transgenic mice.

Authors:  Robert H Whitehead; Pamela S Robinson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-24       Impact factor: 4.052

Review 5.  A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis.

Authors:  Daniella A Babu; Tye G Deering; Raghavendra G Mirmira
Journal:  Mol Genet Metab       Date:  2007-07-30       Impact factor: 4.797

6.  Cell cycle control and DNA damage response of conditionally immortalized urothelial cells.

Authors:  Bradley P Dixon; Jeff Henry; Brian J Siroky; Albert Chu; Pamela A Groen; John J Bissler
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

7.  PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform.

Authors:  Shi-He Liu; Donald D Rao; John Nemunaitis; Neil Senzer; Guisheng Zhou; David Dawson; Marie-Claude Gingras; Zhaohui Wang; Richard Gibbs; Michael Norman; Nancy S Templeton; Francesco J Demayo; Bert O'Malley; Robbi Sanchez; William E Fisher; F Charles Brunicardi
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.